Catalent | الربح الإجمالي على المبيعات



Gross Profit On Sales تغيير تاريخ
Agilent USD 866M 33M 2025-04
AstraZeneca USD 11.35B 819M 2025-03
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Bruker USD 391.2M 102.1M 2025-03
Centene USD 5.2B 1.48B 2025-03
Charles River Laboratories USD 340.1M 20.42M 2025-03
Cigna USD 6.61B 144M 2025-03
Danaher USD 3.53B 364M 2025-03
Dentsply International USD 466M 11M 2025-03
Elevance Health 11.94B 215M 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
Glaxosmithkline GBP 5.6B 94M 2024-12
Hologic USD 560.7M 19.8M 2025-03
Humana 3.83B 3.35B 2024-12
Illumina USD 683M 45M 2025-03
Intuitive Surgical USD 1.46B 184.5M 2025-03
IQVIA Holdings USD 1.3B 80M 2025-03
J&J USD 14.6B 816M 2025-03
Laboratory Of America USD 948M 51.7M 2025-03
Lonza CHF 1.04B 72M 2024-12
McKesson USD 3.38B 126M 2025-03
Merck EUR 3.14B 46M 2025-03
Merck USD 12.77B 849M 2025-03
Mettler Toledo International USD 525.88M 113.44M 2025-03
Novartis USD 10.23B 294M 2024-12
Pfizer USD 11.12B 987M 2025-03
Quest Diagnostics USD 869M 11M 2025-03
Repligen USD 90.76M 10.44M 2025-03
Revvity USD 375.55M 36.74M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
Thermo Fisher Scientific USD 4.31B 514M 2025-03
UnitedHealth 21.31B 1.72B 2024-12
Waters USD 384.96M 139.24M 2025-03
West Pharmaceutical Services USD 231.9M 41.7M 2025-03



Catalent الربح الإجمالي على المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.